Logo image of MCHPP

MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28 (MCHPP) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:MCHPP - US5950173022

61.26 USD
+0.92 (+1.52%)
Last: 12/8/2025, 4:26:30 PM
Fundamental Rating

4

Overall MCHPP gets a fundamental rating of 4 out of 10. We evaluated MCHPP against 112 industry peers in the Semiconductors & Semiconductor Equipment industry. MCHPP has an average financial health and profitability rating. While showing a medium growth rate, MCHPP is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

MCHPP had positive earnings in the past year.
MCHPP had a positive operating cash flow in the past year.
MCHPP had positive earnings in 4 of the past 5 years.
In the past 5 years MCHPP always reported a positive cash flow from operatings.
MCHPP Yearly Net Income VS EBIT VS OCF VS FCFMCHPP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

1.2 Ratios

MCHPP has a Return On Assets (-1.69%) which is comparable to the rest of the industry.
MCHPP has a Return On Equity of -3.66%. This is comparable to the rest of the industry: MCHPP outperforms 41.07% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.91%, MCHPP is in line with its industry, outperforming 50.89% of the companies in the same industry.
MCHPP had an Average Return On Invested Capital over the past 3 years of 11.93%. This is in line with the industry average of 10.82%.
The last Return On Invested Capital (0.91%) for MCHPP is well below the 3 year average (11.93%), which needs to be investigated, but indicates that MCHPP had better years and this may not be a problem.
Industry RankSector Rank
ROA -1.69%
ROE -3.66%
ROIC 0.91%
ROA(3y)8.56%
ROA(5y)7.14%
ROE(3y)20.99%
ROE(5y)18.26%
ROIC(3y)11.93%
ROIC(5y)10.28%
MCHPP Yearly ROA, ROE, ROICMCHPP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

1.3 Margins

MCHPP has a Operating Margin (3.68%) which is in line with its industry peers.
MCHPP's Operating Margin has declined in the last couple of years.
MCHPP has a better Gross Margin (54.06%) than 71.43% of its industry peers.
In the last couple of years the Gross Margin of MCHPP has declined.
Industry RankSector Rank
OM 3.68%
PM (TTM) N/A
GM 54.06%
OM growth 3Y-32.35%
OM growth 5Y-8.3%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.92%
GM growth 5Y-1.82%
MCHPP Yearly Profit, Operating, Gross MarginsMCHPP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MCHPP is still creating some value.
MCHPP has more shares outstanding than it did 1 year ago.
MCHPP has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, MCHPP has an improved debt to assets ratio.
MCHPP Yearly Shares OutstandingMCHPP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
MCHPP Yearly Total Debt VS Total AssetsMCHPP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

MCHPP has an Altman-Z score of 3.46. This indicates that MCHPP is financially healthy and has little risk of bankruptcy at the moment.
MCHPP has a Altman-Z score of 3.46. This is comparable to the rest of the industry: MCHPP outperforms 50.00% of its industry peers.
The Debt to FCF ratio of MCHPP is 7.13, which is on the high side as it means it would take MCHPP, 7.13 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of MCHPP (7.13) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.80 indicates that MCHPP is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.80, MCHPP is doing worse than 81.25% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 7.13
Altman-Z 3.46
ROIC/WACC0.09
WACC10.12%
MCHPP Yearly LT Debt VS Equity VS FCFMCHPP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.3 Liquidity

MCHPP has a Current Ratio of 2.25. This indicates that MCHPP is financially healthy and has no problem in meeting its short term obligations.
MCHPP has a worse Current ratio (2.25) than 68.75% of its industry peers.
A Quick Ratio of 1.20 indicates that MCHPP should not have too much problems paying its short term obligations.
The Quick ratio of MCHPP (1.20) is worse than 81.25% of its industry peers.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 1.2
MCHPP Yearly Current Assets VS Current LiabilitesMCHPP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

4

3. Growth

3.1 Past

The earnings per share for MCHPP have decreased strongly by -64.77% in the last year.
MCHPP shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -14.29% yearly.
The Revenue for MCHPP has decreased by -23.36% in the past year. This is quite bad
Measured over the past years, MCHPP shows a decrease in Revenue. The Revenue has been decreasing by -3.55% on average per year.
EPS 1Y (TTM)-64.77%
EPS 3Y-34.42%
EPS 5Y-14.29%
EPS Q2Q%-23.91%
Revenue 1Y (TTM)-23.36%
Revenue growth 3Y-13.58%
Revenue growth 5Y-3.55%
Sales Q2Q%-2.01%

3.2 Future

MCHPP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.55% yearly.
MCHPP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.85% yearly.
EPS Next Y12.78%
EPS Next 2Y39.7%
EPS Next 3Y41.47%
EPS Next 5Y29.55%
Revenue Next Year3.21%
Revenue Next 2Y10.83%
Revenue Next 3Y13.73%
Revenue Next 5Y9.85%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MCHPP Yearly Revenue VS EstimatesMCHPP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
MCHPP Yearly EPS VS EstimatesMCHPP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 65.87, MCHPP can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as MCHPP.
The average S&P500 Price/Earnings ratio is at 26.34. MCHPP is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 24.15 indicates a rather expensive valuation of MCHPP.
Based on the Price/Forward Earnings ratio, MCHPP is valued a bit cheaper than 76.79% of the companies in the same industry.
MCHPP is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.56, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 65.87
Fwd PE 24.15
MCHPP Price Earnings VS Forward Price EarningsMCHPP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MCHPP is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MCHPP indicates a somewhat cheap valuation: MCHPP is cheaper than 70.54% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 43.89
EV/EBITDA 43.25
MCHPP Per share dataMCHPP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MCHPP does not grow enough to justify the current Price/Earnings ratio.
MCHPP's earnings are expected to grow with 41.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.15
PEG (5Y)N/A
EPS Next 2Y39.7%
EPS Next 3Y41.47%

4

5. Dividend

5.1 Amount

MCHPP has a Yearly Dividend Yield of 2.81%.
MCHPP's Dividend Yield is rather good when compared to the industry average which is at 2.09. MCHPP pays more dividend than 93.75% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.31, MCHPP pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.81%

5.2 History

On average, the dividend of MCHPP grows each year by 20.15%, which is quite nice.
MCHPP does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)20.15%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of MCHPP are negative and hence is the payout ratio. MCHPP will probably not be able to sustain this dividend level.
The dividend of MCHPP is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-421.71%
EPS Next 2Y39.7%
EPS Next 3Y41.47%
MCHPP Yearly Income VS Free CF VS DividendMCHPP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28

NASDAQ:MCHPP (12/8/2025, 4:26:30 PM)

61.26

+0.92 (+1.52%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-04 2026-02-04/amc
Inst Owners98.37%
Inst Owner ChangeN/A
Ins Owners1.93%
Ins Owner ChangeN/A
Market Cap33.11B
Revenue(TTM)4.21B
Net Income(TTM)-245.10M
Analysts79.39
Price Target68.98 (12.6%)
Short Float %0.15%
Short Ratio5.59
Dividend
Industry RankSector Rank
Dividend Yield 2.81%
Yearly Dividend1.81
Dividend Growth(5Y)20.15%
DP-421.71%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.19%
Min EPS beat(2)2.58%
Max EPS beat(2)11.8%
EPS beat(4)3
Avg EPS beat(4)-2.68%
Min EPS beat(4)-27.71%
Max EPS beat(4)11.8%
EPS beat(8)5
Avg EPS beat(8)-0.82%
EPS beat(12)5
Avg EPS beat(12)-1.03%
EPS beat(16)7
Avg EPS beat(16)-0.46%
Revenue beat(2)0
Avg Revenue beat(2)-0.83%
Min Revenue beat(2)-1.6%
Max Revenue beat(2)-0.05%
Revenue beat(4)0
Avg Revenue beat(4)-1.89%
Min Revenue beat(4)-4.74%
Max Revenue beat(4)-0.05%
Revenue beat(8)0
Avg Revenue beat(8)-1.9%
Revenue beat(12)0
Avg Revenue beat(12)-1.88%
Revenue beat(16)0
Avg Revenue beat(16)-1.69%
PT rev (1m)-4.2%
PT rev (3m)-4.71%
EPS NQ rev (1m)-2.66%
EPS NQ rev (3m)-4.93%
EPS NY rev (1m)-2.33%
EPS NY rev (3m)-3.31%
Revenue NQ rev (1m)-1.44%
Revenue NQ rev (3m)-3.48%
Revenue NY rev (1m)-2.05%
Revenue NY rev (3m)-2.14%
Valuation
Industry RankSector Rank
PE 65.87
Fwd PE 24.15
P/S 7.86
P/FCF 43.89
P/OCF 39.36
P/B 4.94
P/tB N/A
EV/EBITDA 43.25
EPS(TTM)0.93
EY1.52%
EPS(NY)2.54
Fwd EY4.14%
FCF(TTM)1.4
FCFY2.28%
OCF(TTM)1.56
OCFY2.54%
SpS7.79
BVpS12.39
TBVpS-4.01
PEG (NY)5.15
PEG (5Y)N/A
Graham Number16.1
Profitability
Industry RankSector Rank
ROA -1.69%
ROE -3.66%
ROCE 1.16%
ROIC 0.91%
ROICexc 0.93%
ROICexgc 2.84%
OM 3.68%
PM (TTM) N/A
GM 54.06%
FCFM 17.91%
ROA(3y)8.56%
ROA(5y)7.14%
ROE(3y)20.99%
ROE(5y)18.26%
ROIC(3y)11.93%
ROIC(5y)10.28%
ROICexc(3y)12.2%
ROICexc(5y)10.52%
ROICexgc(3y)48.65%
ROICexgc(5y)43.88%
ROCE(3y)15.1%
ROCE(5y)13.02%
ROICexgc growth 3Y-44.39%
ROICexgc growth 5Y-17.88%
ROICexc growth 3Y-40.07%
ROICexc growth 5Y-9.14%
OM growth 3Y-32.35%
OM growth 5Y-8.3%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.92%
GM growth 5Y-1.82%
F-Score3
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 7.13
Debt/EBITDA 6.16
Cap/Depr 12.08%
Cap/Sales 2.06%
Interest Coverage 250
Cash Conversion 96.37%
Profit Quality N/A
Current Ratio 2.25
Quick Ratio 1.2
Altman-Z 3.46
F-Score3
WACC10.12%
ROIC/WACC0.09
Cap/Depr(3y)32.64%
Cap/Depr(5y)27.66%
Cap/Sales(3y)4.12%
Cap/Sales(5y)3.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-64.77%
EPS 3Y-34.42%
EPS 5Y-14.29%
EPS Q2Q%-23.91%
EPS Next Y12.78%
EPS Next 2Y39.7%
EPS Next 3Y41.47%
EPS Next 5Y29.55%
Revenue 1Y (TTM)-23.36%
Revenue growth 3Y-13.58%
Revenue growth 5Y-3.55%
Sales Q2Q%-2.01%
Revenue Next Year3.21%
Revenue Next 2Y10.83%
Revenue Next 3Y13.73%
Revenue Next 5Y9.85%
EBIT growth 1Y-86.35%
EBIT growth 3Y-41.54%
EBIT growth 5Y-11.55%
EBIT Next Year54.95%
EBIT Next 3Y42.38%
EBIT Next 5Y25.08%
FCF growth 1Y-76.11%
FCF growth 3Y-32.16%
FCF growth 5Y-12.16%
OCF growth 1Y-76.62%
OCF growth 3Y-31.89%
OCF growth 5Y-10.27%

MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28 / MCHPP FAQ

Can you provide the ChartMill fundamental rating for MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28?

ChartMill assigns a fundamental rating of 4 / 10 to MCHPP.


What is the valuation status for MCHPP stock?

ChartMill assigns a valuation rating of 3 / 10 to MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28 (MCHPP). This can be considered as Overvalued.


How profitable is MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28 (MCHPP) stock?

MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28 (MCHPP) has a profitability rating of 4 / 10.


What is the valuation of MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28 based on its PE and PB ratios?

The Price/Earnings (PE) ratio for MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28 (MCHPP) is 65.87 and the Price/Book (PB) ratio is 4.94.


Can you provide the expected EPS growth for MCHPP stock?

The Earnings per Share (EPS) of MICROCHIP TECHNOLOGY INC - MCHP 7 1/2 03/15/28 (MCHPP) is expected to grow by 12.78% in the next year.